(Q36656424)

English

Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls

scientific article published on January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls (English)

1 reference

Europe PubMed Central

15 August 2017

1 reference

based on heuristic

inferred from title

author name string

Serge Cremers

1

1 reference

Europe PubMed Central

15 August 2017

Patrick Garnero

2

1 reference

Europe PubMed Central

15 August 2017

publication date

1 January 2006

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

66

1 reference

Europe PubMed Central

15 August 2017

16

1 reference

Europe PubMed Central

15 August 2017

2031-2058

1 reference

Europe PubMed Central

15 August 2017

https://scigraph.springernature.com/pub.10.2165/00003495-200666160-00001

0 references

Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666160-00001

21 January 2018

Metastasis to bone: causes, consequences and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200666160-00001

21 January 2018

Atrasentan: a novel and rationally designed therapeutic alternative in the management of cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular markers of bone turnover: biochemical, technical and analytical aspects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: a double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Skeletal complications of malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous pamidronate in patients with tumor-induced osteolysis: a biochemical dose-response study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pamidronate in the prevention of chemotherapy-induced bone loss in premenopausal women with breast cancer: a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical markers and skeletal metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Strontium ranelate inhibits bone resorption while maintaining bone formation in alveolar bone in monkeys (Macaca fascicularis).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early changes in serum N-telopeptide and C-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly women

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The anabolic effects of parathyroid hormone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of therapeutic response in patients with metastatic bone disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diurnal variation of bone mineral turnover in elderly men and women.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A semimechanistic and mechanistic population PK-PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) region

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The type I collagen fragments ICTP and CTX reveal distinct enzymatic pathways of bone collagen degradation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics/pharmacodynamics of bisphosphonates: use for optimisation of intermittent therapy for osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoblast and osteoclast activity in a malignant infantile osteopetrosis patient following bone marrow transplantation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations for the registration of agents to be used in the prevention and treatment of glucocorticoid-induced osteoporosis: updated recommendations from the Group for the Respect of Ethics and Excellence in Science

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of bone metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of action and therapeutic potential of strontium in bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paget's disease of bone: clinical, pathogenetic and therapeutic aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How useful are measures of BMD and bone turnover?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34): a randomized controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical markers of bone remodeling

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The human alkaline phosphatases: what we know and what we don't know

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy, or combination therapy: a three-year, double-blind, placebo-controlled,

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical use of markers of bone turnover in metastatic bone disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical management of osteoporosis in women with a history of breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple myeloma: review of 869 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early changes in urinary cross-linked N-terminal telopeptides of type I collagen level correlate with 1-year response of lumbar bone mineral density to alendronate in postmenopausal Japanese women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical markers as surrogates in clinical trials in patients with metastatic bone disease and osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive value of bone resorption and formation markers in cancer patients with bone metastases receiving the bisphosphonate zoledronic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical markers of bone metabolism and prediction of fracture in elderly women.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An immunoassay for measuring fragments of newly synthesized collagen type I produced during metastatic invasion of bone.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of prostate cancer induced bone remodeling by the endothelin receptor A antagonist atrasentan

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased beta-isomerization of the C-terminal telopeptide of type I collagen alpha 1 chain in Paget's disease of bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of bone metastases in cancer: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of male osteoporosis: report of the UK Consensus Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The divalent strontium salt S12911 enhances bone cell replication and bone formation in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous zoledronic acid in postmenopausal women with low bone mineral density

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of low doses of stable strontium on bone metabolism in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoporosis during androgen deprivation therapy for prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can bone markers guide more effective treatment of bone metastases from breast cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tartrate-resistant acid phosphatase 5b: a novel serum marker of bone resorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early response in biochemical markers predicts long-term response in bone mass during hormone replacement therapy in early postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tartrate-resistant acid phosphatase 5b is a useful serum marker for extensive bone metastasis in breast cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoclast-derived serum tartrate-resistant acid phosphatase 5b in Albers-Schonberg disease (type II autosomal dominant osteopetrosis).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring individual response to hormone replacement therapy with bone markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human liver plasma membranes contain an enzyme activity that removes membrane anchor from alkaline phosphatase and converts it to a plasma-like form

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Denosumab in postmenopausal women with low bone mineral density

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Change in bone turnover and hip, non-spine, and vertebral fracture in alendronate-treated women: the fracture intervention trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis--a 2-year randomized placebo controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parathyroid hormone as an anabolic skeletal therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic bone disease: clinical features, pathophysiology and treatment strategies

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The management of Paget's disease of bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone remodeling and calcium metabolism: A correlated histomorphometric, calcium kinetic, and biochemical study in patients with osteoporosis and Paget's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations for zoledronic acid treatment of patients with bone metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigation of bone disease using isomerized and racemized fragments of type I collagen

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates: clinical experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical use of biochemical markers of bone remodeling: current status and future directions

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble RANKL and risk of nontraumatic fracture

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metabolic effects of single-dose pamidronate administration in prostate cancer patients with bone metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological therapy of Paget's and other metabolic bone diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating osteoprotegerin and receptor activator for nuclear factor kappaB ligand: clinical utility in metabolic bone disease assessment

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind, randomised, placebo-controlled, dose-finding study of oral ibandronate in patients with metastatic bone disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone remodeling: biochemical markers or bone biopsy?

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum TRACP 5b is a useful marker for monitoring alendronate treatment: comparison with other markers of bone turnover

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone resorption predicts for skeletal complications in metastatic bone disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationships between biochemical and symptomatic response in a double-blind randomised trial of pamidronate for metastatic bone disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Markers of bone turnover for the management of patients with bone metastases from prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17112299

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00003495-200666160-00001

1 reference

Europe PubMed Central

15 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36656424&oldid=1643187455"